课题基金 / 基金详情

基于TNFα/ERK/NF-E2非经典途径研究地榆酚酸DMAG促进巨核细胞末期分化与成熟的分子机制

批准号:
82074129
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
吴建明
依托单位:
学科分类:
中药学研究新技术与新方法
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
吴建明

项目摘要

结项摘要

吴建明的其他基金

相似基金

相关文献

中文摘要
血小板减少导致的出血长期困扰临床,治疗的关键是刺激巨核细胞分化与成熟进而促血小板生成。TNFα可正向调控这一过程,但其机制尚未阐明。我们前期研究发现:地榆酚酸(DMAG)为中药地榆促血小板生成的关键成分,核心作用靶点为TNFα,通过上调TNFα表达,浓度依赖地促进巨核细胞分化与成熟,增加胞内微管蛋白表达及ERK磷酸化,触发核内NF-E2高表达,提高小鼠血小板水平,然而DMAG对TPO核心下游通路JAK/STAT无明显影响。由上推测:DMAG通过非依赖TPO的TNFα/ERK/NF-E2通路促巨核细胞分化与成熟。本课题拟以TNFR1-/-巨核细胞及TNFR1-/-小鼠为模型,运用流式细胞术、全荧光小鼠、单细胞测序等证明:①TNFα/ERK为一条新型促血小板生成调控通路;②DMAG通过上调该通路促血小板生成。本课题将从新视角阐释地榆止血功效的科学内涵,有望为发掘新型促血小板生成药物提供新思路。
英文摘要
Bleeding caused by thrombocytopenia is the frequent and serious problem in clinic, while the differentiation and maturation of megakaryocytes play the critical roles to improve the platelet production in the treatment of thrombocytopenia. TNFα/ERK pathway is associated with positive regulation of thrombopoiesis, however, the molecular mechanism has not been fully understood so far. Our previous study found that 3,4'-O-dimethylellagic acid-4-O-α-D-glucoside (DMAG) isolated from Sanguisorba officinalis L. was the most potent compound for the treatment of thrombocytopenia. More interestingly, we found that DMAG did not affect the well-recognized TPO/c-Mpl pathway but remarkabely improve the mRNA expression of TNFα by the qRT-PCR experiments. Furthermore, DMAG could significantly accelerate the differentiation and maturation of megakaryocytes, as well as promote intracellular tubulin expressions and ERK phosphorylations, then induce the consecutively potent expressions of NF-E2 in the megakaryocytic nucleus leading to the terminal platelet production and release. In summary, our findings indicate that DMAG can accelerate the terminal differentiation and maturation of megakaryocytes through the TNFα/ERK/NF-E2 pathway. The present study will use the TNFR1-/- megakaryocytes and TNFR1-/- knockout mice to block the interference of TPO/c-Mpl pathway, then investigate the phenotypes of differentiation and maturation in vitro and in vivo. Meanwhile, we will explore the associated mechanism of DMAG promoting thrombopoiesis by the flow cytometry, full-fluorescent mice, single-cell sequencing and other methods. This research is not only the continuation and development of our previous studies, but also an intensive study of the Sanguisorba officinalis’s hemostatic efficacy, which may make a novel approach for clinical therapeutic strategies.
血小板减少导致的出血长期困扰临床,治疗的关键是刺激巨核细胞分化与成熟进而促血小板生成。TNFα可正向调控这一过程,但其机制尚未阐明。课题组前期发现地榆酚酸(DMAG)为中药地榆促血小板生成的关键成分,核心作用靶点为TNFα,通过上调TNFα表达,浓度依赖地促进巨核细胞分化与成熟,增加胞内微管蛋白表达及ERK磷酸化,触发核内NF-E2高表达,提高小鼠血小板水平,然而DMAG对TPO核心下游通路JAK/STAT无明显影响。本课题设想DMAG通过非依赖TPO的TNFα/ERK/NF-E2通路促巨核细胞分化与成熟。为此,本项目采用TNFR1敲低巨核细胞及TNFR1-/-小鼠等为模型,综合流式细胞术和组学技术研究DMAG促巨核细胞成熟分化的体内外活性及治疗作用。靶点筛选实验显示:在分子动态结合模拟中DMAG与TNFR1有稳定结合;网络药理学分析显示TNF为DMAG治疗血小板减少症的核心蛋白质;通过蛋白质印迹法检测DMAG显著上调了TNFR1蛋白表达。体外实验结果显示:DMAG能够明显增加HEL和Meg-01细胞体积及多核细胞数目,促进微管蛋白的胞内表达以及巨核细胞的多倍体化;同时,DMAG干预细胞后CD41+CD42b+表达上调,β1-tublin标记的细胞质伸出细丝,多倍体的数量增加,核荧光显著增强;在TNFR1过表达和敲低细胞株中,DMAG能显著促进野生型及TNFR1过表达细胞的分化形态,但无法促进TNFR1低表达细胞的分化形态。体内实验结果显示:DMAG能显著缓解放射损伤导致的血小板水平的降低,促进血小板水平的恢复;DMAG治疗后骨髓巨核细胞的生成、vWF和CD41/CD61的表达也相应增强,显著恢复血小板减少症小鼠的血小板聚集、黏附以及凝血功能;在c-MPL-/-小鼠模型中,DMAG也显示出促巨核细胞分化和血小板生成的作用。机制研究结果显示:DMAG可激活TNF-α和MAPK信号通路,上调TNF-α、TNFR1、P-ERK、β-tublin以及NF-E2的表达。NF-E2-siRNA沉默NF-E2蛋白表达后,DMAG促巨核细胞的分化作用被显著抑制,另TNF-α受体拮抗剂以及ERK抑制剂能分别抑制相关通路蛋白的表达。上述结果提示,DMAG通过非经典途径促巨核细胞成熟,对丰富地榆“止血”功效学内涵,深化中医药的现代医学基础具有重要意义,有望为临床治疗提供新的治疗策略。
基于TPO与TNFα通路的crosstalk研究地榆止血功效成分TMEA/DMAG共同调控血小板生成稳态的分子机制
  • 批准号:
    82374073
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    吴建明
  • 依托单位:
地榆单体TMEA通过c-kit/PI3K/Akt途径促巨核细胞分化的分子机制
  • 批准号:
    81774013
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2017
  • 负责人:
    吴建明
  • 依托单位:
国内基金
海外基金